From the Health & Human Services edition of November 3, 2026
WHO South-East Asia and Wadhwani AI sign two-year agreement to evaluate AI in India's public health programmes
WHO Regional Office for South-East Asia (SEARO) and Lords Education and Health Society (Wadhwani AI) · Public health (national programmes; diagnostics, screening, disease tracking) · India and WHO South-East Asia Region (international)
- Publisher
- Digital Health News
- Original publication
- 2026-11-03
- Source retrieved
- 2026-11-04
- Event date
- 2026-11-01
What happened
WHO SEARO and LEHS, through Wadhwani AI, signed a Project Collaboration Agreement running Nov. 1, 2026 to Oct. 31, 2028 to generate evidence on AI in public health programmes through technical briefs, case studies and evaluation reports on design, validation, safety, effectiveness and operational feasibility; document integration pathways and barriers into government digital health platforms; cover the lifecycle for diagnostics and screening, risk stratification, disease tracking and modelling; and build capacity for programme managers and the health workforce.
Why it matters
Limited and indirect: an international model for pairing public health AI deployment with structured, published evaluation. US state and local health departments may use its outputs as reference evidence; nothing deployable yet.
Evidence and measured results
Trade-news report of the agreement; describes intended outputs only. No evaluation results.
Limitations and uncertainty
Non-US, pre-output, and reported by trade press rather than a WHO release reviewed here. Transferability to US public health is limited to evaluation methods.
Put this evidence to work
Lighthouse Advisory interpretation, grounded in this source. Enriched 2026-11-03; this does not change the original publication date. Each role follows the same checklist so takeaways compare across sources.
Sales
Role takeaway
- Customer problem
- Public health agencies lack real-world evidence on AI safety and effectiveness to justify scale.
- Stakeholders
- State and local public health informatics leads
- Epidemiology and surveillance directors
- Program evaluators
- Discovery questions
- How do you evaluate AI pilots before scaling?
- Which evidence would you accept from international programmes?
- Who owns post-deployment monitoring?
- Value hypothesis
- Bounded: an evaluation-first framing may help agencies design pilots that produce decision-grade evidence.
- Potential engagement
- Advisory on evaluation design for one public health AI pilot; no implementation engagement is supported by this source.
- Unsupported claims
- Any measured effect of AI in Indian programmes
- US applicability of results
- Vendor endorsements
Pre-sales engineering
Role takeaway
- Fit
- Context for evaluation and monitoring requirements in public health AI.
- Architecture and integration
- None yet; future guidance on integration with government digital health platforms.
- Prerequisites
- Publication of technical briefs and evaluation reports
- Constraints
- Non-US data systems and populations
- No outputs yet
- Security
- Not specified beyond privacy safeguards.
- Proof of value
- Map future evaluation metrics to a US pilot test plan
Delivery
Role takeaway
- Work
- Monitor outputs; adapt lifecycle evaluation structure for local pilots.
- Dependencies
- WHO SEARO and Wadhwani AI publications
- Ownership
- Public health informatics and evaluation leadership.
- Skills and adoption
- Evaluation literacy for programme managers.
- Governance checkpoints
- Evaluation plan approval before pilot launch
- Acceptance criteria
- Proposed: each local AI pilot has a written validation and monitoring plan
- Risks
- Overstating relevance of non-US evidence
- Outputs delayed or general
Implementation considerations
Lighthouse Advisory interpretation across the operating dimensions a public-sector buyer must settle before this evidence becomes a design. Each note answers the question under its heading for this specific source.
Architecture and integration
What must connect, and where does the AI sit in the workflow?
Emphasis on integration into government digital health platforms signals workflow integration, not standalone pilots, as the evaluated unit.
Governance
Who approves, reviews and stays accountable for outcomes?
Frames real-world safety and effectiveness evidence plus equity, privacy and human-rights safeguards as preconditions for scale.
Security and privacy
What data, permissions and controls need testing?
Privacy named as a safeguard area; no specifics.
Accessibility and workforce
Who is affected, and what skills or accommodations follow?
Includes capacity-building materials for programme managers and health workers.
Procurement
What should contracts, pricing and exit terms secure?
None directly; future evaluation reports could inform evidence requirements in procurement.
Operating model
Which teams own the service once it runs?
Evaluation across the lifecycle from problem identification to monitoring is positioned as a programme function.
Publication history
- 2026-11-03Health & Human Services · Issue 062 resources
Stable resource ID: who-searo-wadhwani-ai-public-health-evidence-agreement-20261103